Todd Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Todd Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-81,452	Closed	-$23M	–	221
2022 Q2	$23M	Sell	81,452 -24,342	-23%	-$6.52M	0.59%	77
2022 Q1	$27.6M	Buy	+105,794	New	+$25.1M	0.61%	77
2020 Q4	–	Sell	-48,833	Closed	-$13.3M	–	217
2020 Q3	$13.3M	Sell	48,833 -979	-2%	-$270K	0.4%	121
2020 Q2	$14.5M	Buy	+49,812	New	+$13.5M	0.46%	98

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Todd Asset Management's VRTX Position: Q3 2022 in Review

Todd Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 81,452 shares — an estimated $23M sold.

Todd Asset Management first reported a position in VRTX in Q2 2020 and held it in 4 quarters. The position peaked at $27.6M in Q1 2022. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

Todd Asset Management reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Todd Asset Management sold 81,452 Vertex Pharmaceuticals shares in Q3 2022, an estimated $23M.
Todd Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and held it in 4 quarters.
Todd Asset Management's Vertex Pharmaceuticals position peaked at $27.6M in Q1 2022.
1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Todd Asset Management's 13F filing for Q3 2022, filed 8 Nov 2022.